As Global Dyslipidemia Therapy Area Lead at Sanofi, commanded strategic vision for >500M€ portfolio and aligned cross-functional team to deliver exceptional +17.2M€ net sales growth over baseline while securing 3.9M€ for key initiatives.
Sanofi GLOBAL·September 2021
As Global Dyslipidemia Therapy Area Lead at Sanofi, commanded strategic vision for >500M€ portfolio and aligned cross-functional team to deliver exceptional +17.2M€ net sales growth over baseline while securing 3.9M€ for key initiatives.